Variant report

Variant	esv3321964
Chromosome Location	chr10:23632396-23633894
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:70)
CpG islands
(count:428)
Chromatin interactive
region (count:1)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:70 , 50 per page) page: 1 2

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CHD2	chr10:23632845-23633445	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTBP2	chr10:23633165-23633740	H1-hESC	embryonic stem cell:	n/a	n/a
3	CTCF	chr10:23632840-23632990	HCPEpiC	choroid plexus:	n/a	n/a
4	CTCF	chr10:23632860-23633010	SK-N-SH_RA	brain:	n/a	n/a
5	CTCF	chr10:23633460-23633610	HCPEpiC	choroid plexus:	n/a	n/a
6	CTCF	chr10:23632940-23632965	NHEK	skin:	n/a	n/a
7	CTCF	chr10:23632860-23633010	SAEC	small airway:	n/a	n/a
8	CTCF	chr10:23632900-23633050	HMEC	breast:	n/a	n/a
9	CTCF	chr10:23632911-23632971	MCF-7	breast:	n/a	n/a
10	EGR1	chr10:23632911-23633046	K562	blood:	n/a	n/a
11	EGR1	chr10:23633134-23633598	H1-hESC	embryonic stem cell:	n/a	n/a
12	EGR1	chr10:23632816-23633102	ECC-1	luminal epithelium:	n/a	chr10:23633050-23633060 chr10:23633039-23633052 chr10:23633035-23633057 chr10:23633041-23633051 chr10:23633039-23633052
13	EGR1	chr10:23632876-23633056	K562	blood:	n/a	chr10:23633039-23633052 chr10:23633041-23633051 chr10:23633039-23633052
14	EGR1	chr10:23632797-23633222	ECC-1	luminal epithelium:	n/a	chr10:23633050-23633060 chr10:23633039-23633052 chr10:23633035-23633057 chr10:23633041-23633051 chr10:23633039-23633052
15	GTF2F1	chr10:23633452-23633463	H1-hESC	embryonic stem cell:	n/a	n/a
16	JUND	chr10:23633566-23633661	H1-hESC	embryonic stem cell:	n/a	n/a
17	MAX	chr10:23632708-23633724	H1-hESC	embryonic stem cell:	n/a	chr10:23633044-23633054
18	MAX	chr10:23632824-23633653	H1-hESC	embryonic stem cell:	n/a	chr10:23633044-23633054
19	MAX	chr10:23633413-23633415	A549	lung:	n/a	n/a
20	MAX	chr10:23633114-23633870	SK-N-SH	brain:	n/a	n/a
21	MAX	chr10:23633104-23633892	SK-N-SH	brain:	n/a	n/a
22	MAX	chr10:23633171-23633650	A549	lung:	n/a	n/a
23	MAX	chr10:23633139-23633767	H1-hESC	embryonic stem cell:	n/a	n/a
24	MAX	chr10:23632706-23633078	H1-hESC	embryonic stem cell:	n/a	chr10:23633044-23633054
25	MXI1	chr10:23632818-23633087	H1-hESC	embryonic stem cell:	n/a	n/a
26	MXI1	chr10:23633403-23633603	H1-hESC	embryonic stem cell:	n/a	n/a
27	MXI1	chr10:23633216-23633857	IMR90	lung:	n/a	n/a
28	MYC	chr10:23633216-23633489	MCF-7	breast:	n/a	n/a
29	MYC	chr10:23633288-23633531	H1-hESC	embryonic stem cell:	n/a	n/a
30	POLR2A	chr10:23633144-23633831	H1-neurons	neurons:	n/a	n/a
31	POLR2A	chr10:23633331-23633340	Gliobla	brain:	n/a	n/a
32	POLR2A	chr10:23632557-23633058	H1-hESC	embryonic stem cell:	n/a	n/a
33	POLR2A	chr10:23633173-23633750	U87	brain:	n/a	n/a
34	POLR2A	chr10:23633231-23633517	MCF-7	breast:	n/a	n/a
35	POLR2A	chr10:23633306-23633433	MCF-7	breast:	n/a	n/a
36	POLR2A	chr10:23633262-23633807	SK-N-SH	brain:	n/a	n/a
37	POLR2A	chr10:23633157-23633909	SK-N-SH	brain:	n/a	n/a
38	POLR2A	chr10:23633393-23633470	Gliobla	brain:	n/a	n/a
39	POLR2A	chr10:23633179-23633744	U87	brain:	n/a	n/a
40	POLR2A	chr10:23633356-23633382	Gliobla	brain:	n/a	n/a
41	POLR2A	chr10:23632612-23633070	U87	brain:	n/a	n/a
42	POLR2A	chr10:23632771-23633765	H1-neurons	neurons:	n/a	n/a
43	POLR2A	chr10:23633269-23633495	H1-hESC	embryonic stem cell:	n/a	n/a
44	POLR2A	chr10:23633174-23633642	U87	brain:	n/a	n/a
45	POLR2A	chr10:23633219-23633234	H1-hESC	embryonic stem cell:	n/a	n/a
46	POLR2A	chr10:23633526-23633673	MCF-7	breast:	n/a	n/a
47	POLR2A	chr10:23633313-23633328	Gliobla	brain:	n/a	n/a
48	POLR2A	chr10:23633764-23633873	MCF10A-Er-Src	breast:	n/a	n/a
49	POLR2A	chr10:23632721-23633093	H1-neurons	neurons:	n/a	n/a
50	RAD21	chr10:23633350-23633544	H1-hESC	embryonic stem cell:	n/a	n/a

(count:428 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr10:23633066-23633116	AG09319	gingival:	n/a
2	chr10:23633066-23633116	AG09319	gingival:	n/a
3	chr10:23633066-23633116	H1-hESC	embryonic stem cell:	embryo
4	chr10:23633390-23633440	HCT-116	colon:	n/a
5	chr10:23632825-23632875	ovcar-3	ovarian:	n/a
6	chr10:23632740-23632790	SAEC	small airway:	n/a
7	chr10:23633390-23633440	Hela-S3	cervix:	n/a
8	chr10:23633759-23633809	H1-hESC	embryonic stem cell:	embryo
9	chr10:23633066-23633116	PrEC	prostate:	n/a
10	chr10:23632740-23632790	HCF	heart:	n/a
11	chr10:23633759-23633809	AG04450	lung:	fetal
12	chr10:23633390-23633440	HUVEC	blood vessel:	n/a
13	chr10:23632740-23632790	BJ	skin:	n/a
14	chr10:23633326-23633376	HCPEpiC	choroid plexus:	n/a
15	chr10:23632740-23632790	HMEC	breast:	n/a
16	chr10:23633759-23633809	SK-N-SH	brain:	n/a
17	chr10:23633759-23633809	Caco-2	colon:	n/a
18	chr10:23632825-23632875	SKMC	muscle:	n/a
19	chr10:23633759-23633809	HL-60	blood:	n/a
20	chr10:23633326-23633376	HCT-116	colon:	n/a
21	chr10:23633390-23633440	Jurkat	blood:	n/a
22	chr10:23633066-23633116	GM12891	blood:	n/a
23	chr10:23633759-23633809	PrEC	prostate:	n/a
24	chr10:23633759-23633809	SK-N-SH_RA	brain:	n/a
25	chr10:23633390-23633440	ovcar-3	ovarian:	n/a
26	chr10:23633066-23633116	LNCaP	prostate:	n/a
27	chr10:23633066-23633116	AG04449	skin:	fetal
28	chr10:23633066-23633116	NB4	blood:	n/a
29	chr10:23632825-23632875	HAEpiC	amniotic membrane:	n/a
30	chr10:23633759-23633809	HepG2	liver:	n/a
31	chr10:23632740-23632790	MCF10A-Er-Src	breast:	n/a
32	chr10:23633759-23633809	GM12892	blood:	n/a
33	chr10:23633518-23633568	GM19239	blood:	n/a
34	chr10:23632740-23632790	HAEpiC	amniotic membrane:	n/a
35	chr10:23633518-23633568	GM12878	blood:	n/a
36	chr10:23632825-23632875	HL-60	blood:	n/a
37	chr10:23633759-23633809	PANC-1	pancreas:	n/a
38	chr10:23633759-23633809	GM19239	blood:	n/a
39	chr10:23632740-23632790	HPAEpiC	pulmonary alveolar:	n/a
40	chr10:23633390-23633440	GM06990	blood:	n/a
41	chr10:23633326-23633376	NHDF-neo	bronchial:	n/a
42	chr10:23632740-23632790	GM19239	blood:	n/a
43	chr10:23633326-23633376	HepG2	liver:	n/a
44	chr10:23633759-23633809	AoSMC	blood vessel:	n/a
45	chr10:23633759-23633809	HNPCEpiC	eye:	n/a
46	chr10:23633066-23633116	Jurkat	blood:	n/a
47	chr10:23633390-23633440	BJ	skin:	n/a
48	chr10:23633066-23633116	T-47D	breast:	n/a
49	chr10:23633518-23633568	NB4	blood:	n/a
50	chr10:23633759-23633809	HCT-116	colon:	n/a

(count:1 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr10:23631888..23635089-chr10:23727661..23730060,4	MCF-7	breast:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-OTUD1-1	chr10:23632886-23633019	ENSG00000224215.1
2	lnc-OTUD1-1	chr10:23633353-23634110	ENSG00000224215.1

No data

Variant related genes	Relation type
ENSG00000224215	TF binding region
C10orf67	TF binding region
ENSG00000224215	CpG island
C10orf67	CpG island
ENSG00000165312	chromatin interactions

Extended variants
information (count: 61 )
Associated
traits (count: 38 )

Variant overlapped rSNPs/rCNVs (count:61 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs568792029	chr10:23632419-23632420	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	Chromatin interactive region	1 gene(s)	Overlapped CNVs	n/a
2	rs562038468	chr10:23632454-23632455	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs189944695	chr10:23632462-23632463	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs182586990	chr10:23632476-23632477	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs113626727	chr10:23632540-23632541	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs532292037	chr10:23632545-23632546	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs552016807	chr10:23632646-23632647	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs151182754	chr10:23632667-23632668	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs10466084	chr10:23632710-23632711	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs559009726	chr10:23632722-23632723	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs568050503	chr10:23632758-23632759	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs534423126	chr10:23632789-23632790	Bivalent/Poised TSS Bivalent Enhancer Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs186363245	chr10:23632834-23632835	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs577480861	chr10:23632860-23632861	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs10466085	chr10:23632864-23632865	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs556531223	chr10:23632889-23632890	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	Chromatin interactive region lncRNA	1 gene(s)	Overlapped CNVs	n/a
17	rs576429679	chr10:23632906-23632907	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
18	rs541848491	chr10:23632909-23632910	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
19	rs562244495	chr10:23632919-23632920	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
20	rs572183373	chr10:23632963-23632964	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
21	rs541095910	chr10:23632965-23632966	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
22	rs11013408	chr10:23632970-23632971	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs371468466	chr10:23632985-23632986	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
24	rs56317783	chr10:23633025-23633026	Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
25	rs552493573	chr10:23633058-23633059	Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs562633792	chr10:23633078-23633079	Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs531374355	chr10:23633154-23633155	Bivalent/Poised TSS Active TSS Bivalent Enhancer Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs180921460	chr10:23633225-23633226	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs568020065	chr10:23633263-23633264	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs533891019	chr10:23633275-23633276	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs547475638	chr10:23633365-23633366	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
32	rs11013409	chr10:23633368-23633369	Bivalent/Poised TSS Flanking Active TSS Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
33	rs540034338	chr10:23633414-23633415	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
34	rs556854793	chr10:23633431-23633432	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
35	rs371261491	chr10:23633448-23633449	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
36	rs374731966	chr10:23633476-23633477	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
37	rs201986532	chr10:23633501-23633502	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
38	rs372171919	chr10:23633511-23633512	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
39	rs534353994	chr10:23633565-23633566	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
40	rs2036917	chr10:23633566-23633567	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
41	rs199944244	chr10:23633567-23633568	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region CpG island Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
42	rs372154796	chr10:23633598-23633599	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Transcr. at gene 5' and 3' Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
43	rs574489634	chr10:23633604-23633605	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
44	rs567940753	chr10:23633610-23633611	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
45	rs368517868	chr10:23633617-23633618	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
46	rs369162185	chr10:23633633-23633634	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
47	rs373433070	chr10:23633642-23633643	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
48	rs377374770	chr10:23633643-23633644	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
49	rs185191255	chr10:23633660-23633661	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a
50	rs564192134	chr10:23633671-23633672	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region lncRNA	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:38)

Disease	PMID	Source
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Glioblastoma multiforme	21080181	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Phyllodes tumor	17334353	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Gastric cancer	17908304	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Medulloblastoma	21979893	CNVD
Melanoma	18172304	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
Lung cancer	18438408	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Ewing''s sarcoma	17952124	CNVD
Oral cancer	21386901	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20724749	CNVD
Autism	22495311	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
T-cell lymphomas	19863542	CNVD
Esophageal cancer	21851588	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	21364760	CNVD
Acute lymphoblastic leukemia	18458336	CNVD
Behavioral abnormalities	21522184	CNVD
Dysmorphic features	21522184	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Glioblastoma multiforme	22286061	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:380 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr10:23627400-23632600	Weak transcription	Left Ventricle	heart
2	chr10:23628000-23632400	Weak transcription	Muscle Satellite Cultured Cells	--
3	chr10:23628400-23632400	Enhancers	Primary T regulatory cells fromperipheralblood	blood
4	chr10:23628600-23632400	Weak transcription	HMEC	breast
5	chr10:23628600-23632400	Weak transcription	NHEK	skin
6	chr10:23628600-23632600	Enhancers	Primary T helper cells PMA-I stimulated	--
7	chr10:23628600-23632600	Weak transcription	Right Atrium	heart
8	chr10:23628600-23632800	Weak transcription	Liver	Liver
9	chr10:23628800-23632400	Weak transcription	Osteobl	bone
10	chr10:23628800-23632600	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
11	chr10:23629400-23632400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
12	chr10:23630400-23632400	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
13	chr10:23630400-23632400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
14	chr10:23630400-23632400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
15	chr10:23630400-23632400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
16	chr10:23630400-23633200	Weak transcription	Primary T killer naive cells fromperipheralblood	blood
17	chr10:23630400-23633200	Weak transcription	Primary T killer memory cells from peripheral blood	blood
18	chr10:23630600-23632400	Weak transcription	Fetal Kidney	kidney
19	chr10:23630600-23632600	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
20	chr10:23630600-23633200	Weak transcription	Primary T helper naive cells from peripheral blood	blood
21	chr10:23631200-23632400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr10:23631200-23632600	Bivalent Enhancer	Placenta	Placenta
23	chr10:23631400-23632400	Bivalent Enhancer	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
24	chr10:23631400-23633400	Enhancers	Fetal Heart	heart
25	chr10:23631600-23632400	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
26	chr10:23631600-23632400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
27	chr10:23631600-23632400	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
28	chr10:23631600-23632400	Weak transcription	Primary T helper cells fromperipheralblood	blood
29	chr10:23631600-23632600	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
30	chr10:23631800-23632400	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
31	chr10:23631800-23632400	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
32	chr10:23631800-23632400	Enhancers	Ganglion Eminence derived primary cultured neurospheres	brain
33	chr10:23631800-23632400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
34	chr10:23631800-23632600	Weak transcription	Primary T helper memory cells from peripheral blood 1	blood
35	chr10:23632000-23632400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
36	chr10:23632000-23632800	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
37	chr10:23632000-23633400	Enhancers	Lung	lung
38	chr10:23632000-23634000	Active TSS	Brain Hippocampus Middle	brain
39	chr10:23632200-23632400	Active TSS	H9 Derived Neuron Cultured Cells	ES cell derived
40	chr10:23632200-23632400	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
41	chr10:23632200-23632400	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
42	chr10:23632200-23632400	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
43	chr10:23632200-23632400	Enhancers	Brain Substantia Nigra	brain
44	chr10:23632200-23632400	Enhancers	Skeletal Muscle Male	skeletal muscle
45	chr10:23632200-23632400	Enhancers	NH-A	brain
46	chr10:23632200-23632600	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr10:23632200-23632600	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
48	chr10:23632200-23632600	Flanking Bivalent TSS/Enh	HUES64 Cell Line	embryonic stem cell
49	chr10:23632200-23632600	Bivalent Enhancer	IMR90 fetal lung fibroblasts Cell Line	lung
50	chr10:23632200-23632600	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links